Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Solid Tumor, Adult × leronlimab × 1 year × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Other solid neoplasm 1

Conditions

Triple Negative Breast Neoplasms 2 Solid Tumor, Adult 1 Colorectal Neoplasms 1

Interventions

Proton Therapy 3 pembrolizumab 2 toripalimab 1 spartalizumab 1 pazopanib 1 patritumab deruxtecan 1 palbociclib 1 leronlimab 1 Valganciclovir 1 Radiotherapy 1 Paclitaxel 1 Lacteol 1 Interleukin-2 1 Docetaxel 1 Carboplatin 1 Blood Specimen Collection 1 Bevacizumab 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04504942 2026-01-23

Basket Study of Leronlimab (PRO 140) in Patients With CCR5+ Locally Advanced or Metastatic Solid Tumors

CytoDyn, Inc.

Phase 2 Completed

16 enrolled 16 charts

Other solid neoplasm

Solid Tumor, Adult

Data powered by HemOnc (CC BY 4.0) Colophon ⚡